Science
Edesa Biotech's Founder Makes Strategic Investment in the Company
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that the company has entered i
By: manilatimes
- Nov 01 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS